Article Details

EPS for Intra-Cellular Therapies, Inc. (ITCI) Expected At $-0.51; Hercules Technology Growth ...

Retrieved on: 2018-02-28 18:52:30

Tags for this article:

Click the tags to see associated articles and topics

EPS for Intra-Cellular Therapies, Inc. (ITCI) Expected At $-0.51; Hercules Technology Growth .... View article details on hiswai:

Excerpt

<div>It has underperformed by 3.75% the S&P500. Muzinich & Co. Inc. holds 4.03% of its portfolio in Hercules Capital, Inc. for 3.15 million shares. <b>Benchmark Capital</b> Advisors owns 247,162 shares or 2.48% of their US portfolio. Moreover, Silver Capital Management Llc has 1.86% invested in the company for ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up